10 November 2014 - Deborah Wilkes
Perrigo is set to acquire Belgian OTC specialist Omega Pharma in a US$4.5 billion deal that it says will create a “top five global OTC player” with a strong presence in both Europe and North America.
Capitalising on cross-selling opportunities will be high on the agenda at the combined company, with Perrigo promising to take its US OTC store-brand portfolio into continental Europe and launch Omega’s products in the US, Mexico and Australia. Perrigo plans to make cost savings by bringing manufacturing of some Omega products in-house. It also has its eye on more bolt-on acquisitions.
Gain rapid insights into Perrigo's plans with Omega on board with this NEWS EXTRA publication from OTCToolbox, which also covers both company's OTC acquisitions, international growth, and latest financial results.
Around 3,000 words long, this NEWS EXTRA – entitled 'Perrigo pushes into Europe with Omega purchase' – is available to purchase and download immediately from the OTCToolbox website. You can make sure your team is well informed through a Multiple User Licence or a Global Licence.
RAPID INSIGHTS MADE EASY
AVAILABLE TO DOWNLOAD IMMEDIATELY
AS A PDF
See Payment Options box on this page
This NEWS EXTRA is also available as part of an Annual Subscription to the OTCToolbox website (click here to find out more).
For alternative payment options and delivery methods, or other questions, please send an email to enquiries@otctoolbox.com.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.